CUSIP: 33830X104
Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,391,322
-
Share change
-
+45,266
-
Total reported value
-
$997,239,355
-
Put/Call ratio
-
70%
-
Price per share
-
$40.91
-
Number of holders
-
121
-
Value change
-
+$3,352,630
-
Number of buys
-
50
-
Number of sells
-
53
Quarterly Holders Quick Answers
What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2017
-
Previous quarter:
Q2 2017
Recent filing periods for CUSIP 33830X104:
Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q3 2017
As of 30 Sep 2017,
FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,391,322 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., VANGUARD GROUP INC, HealthCor Management, L.P., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, BB BIOTECH AG, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
121
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.